How AI will transform blindness prevention | Manuel Opitz | TEDxTUM

Age-related macular degeneration (AMD) is the most common retinal disease and leads to irreversible blindness. As a relatively new therapy, the treatment is still being optimized. In this talk, Manuel Opitz tells us how he and the ophthalmologists he works with are developing artificial intelligence to enable better, personalized, and thus more effective treatments. Manuel Opitz is a MedTech Entrepreneur, having worked for a handful of startups and co-founding and leading two as CEO. Currently heading deepeye Medical, his goal is to improve healthcare by empowering medical professionals with digital tools to treat their patients better.

A true personification of the phrase “jack of all trades,” Manuel strives to bring together experts from various disciplines to solve challenging healthcare problems. He started off as someone not big on networking earlier in his career, but is now an active facilitator connecting people in HealthTech.